2025
Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
Barbano R, Jabbari B, Sadeghi M, Ukah A, Yue E, Ifantides K, Huang N, Swope D. Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure. Toxins 2025, 17: 148. PMID: 40137921, PMCID: PMC11945862, DOI: 10.3390/toxins17030148.Peer-Reviewed Original ResearchConceptsIncidence of dysphagiaCervical dystoniaComorbid conditionsContinuous health plan enrollmentCohort entry dateRate of dysphagiaRetrospective cohort studyPre-existing dysphagiaHealth plan enrollmentRisk factors of dysphagiaFactors of dysphagiaReal-world studyPotential adverse eventsPotential risk factorsPatient-level dataReal-world analysisAdverse eventsCD patientsCohort studyComorbid neurological conditionsLongitudinal patient-level dataCD diagnosisDysphagiaDysphagia riskPatientsAn update on botulinum toxin treatment of painful diabetic neuropathy, post-traumatic painful neuropathy/neuralgia, post-herpetic neuralgia and occipital neuralgia
Jabbari B, Tohidian A. An update on botulinum toxin treatment of painful diabetic neuropathy, post-traumatic painful neuropathy/neuralgia, post-herpetic neuralgia and occipital neuralgia. Toxicon 2025, 255: 108237. PMID: 39798899, DOI: 10.1016/j.toxicon.2025.108237.Peer-Reviewed Original ResearchConceptsPainful diabetic neuropathyPost-traumatic neuralgiaOccipital neuralgiaPostherpetic neuralgiaMode of treatmentBotulinum toxin treatmentDiabetic neuropathyTreatment of painful diabetic neuropathyPost-herpetic neuralgiaCohort of patientsPain disordersEfficacy criteriaNeuralgiaAmerican Academy of NeurologyLevel of efficacyToxin treatmentAmerican AcademyNeuropathyBotulinum therapyEfficacyPatientsTreatment
2024
Botulinum Toxin Treatment of Psoriasis—A Comprehensive Review
Ghaseminejad-Bandpey A, Etemadmoghadam S, Jabbari B. Botulinum Toxin Treatment of Psoriasis—A Comprehensive Review. Toxins 2024, 16: 449. PMID: 39453225, PMCID: PMC11510791, DOI: 10.3390/toxins16100449.Peer-Reviewed Original ResearchConceptsOpen-label studyClinical trialsAnimal studiesPlacebo-controlled studyInjection of botulinum toxinPsoriatic skin lesionsLevels of interleukinsBotulinum toxin injectionOpen-labelDouble-blindBotulinum toxin treatmentCase reportInflammatory cellsPsoriatic plaquesSkin lesionsSmall dosesToxin injectionToxin treatmentLiterature searchBotulinum toxinRelevant articlesPsoriasisInterleukinHuman dataDose
2018
Botulinum toxin treatment of pain syndromes –an evidence based review
Safarpour Y, Jabbari B. Botulinum toxin treatment of pain syndromes –an evidence based review. Toxicon 2018, 147: 120-128. PMID: 29409817, DOI: 10.1016/j.toxicon.2018.01.017.Peer-Reviewed Original ResearchConceptsLevel B evidencePain syndromeLevel of evidencePelvic painB evidenceMale pelvic pain syndromeChronic low back painTraumatic spinal cord injuryEfficacy of BoNTFemale pelvic painMale pelvic painVastus lateralis imbalanceMyofascial pain syndromePelvic pain syndromePost-herpetic neuralgiaAnterior knee painBotulinum toxin treatmentPainful knee osteoarthritisPost-operative painDifferent pain syndromesLow back painSpinal cord injuryCarpal tunnel syndromeTotal knee arthroplastyRole of BoNT
2016
Botulinum Toxin Treatment in Neurology
Jabbari B. Botulinum Toxin Treatment in Neurology. Seminars In Neurology 2016, 36: 003-004. PMID: 26866489, DOI: 10.1055/s-0036-1571849.Peer-Reviewed Original ResearchBotulinum Toxin Treatment of Neuropathic Pain
Mittal SO, Safarpour D, Jabbari B. Botulinum Toxin Treatment of Neuropathic Pain. Seminars In Neurology 2016, 36: 073-083. PMID: 26866499, DOI: 10.1055/s-0036-1571953.Peer-Reviewed Original ResearchConceptsNeuropathic painBoNT treatmentComplex regional pain syndromeBotulinum toxin treatmentPainful diabetic neuropathyRegional pain syndromeCarpal tunnel syndromePhantom limb painEvidence-based statementsForm of painTechnique of injectionPosttraumatic neuralgiaAnalgesic medicationPain syndromePostherpetic neuralgiaDiabetic neuropathyOccipital neuralgiaLevel of efficacyLimb painTrigeminal neuralgiaTunnel syndromeClinical trialsToxin treatmentPainNeuralgiaBotulinum Toxin Treatment of Spasticity in Adults and Children
Moeini-Naghani I, Hashemi-Zonouz T, Jabbari B. Botulinum Toxin Treatment of Spasticity in Adults and Children. Seminars In Neurology 2016, 36: 064-072. PMID: 26866498, DOI: 10.1055/s-0036-1571847.Peer-Reviewed Original ResearchConceptsCerebral palsyPlacebo-controlled clinical trialDoses of BoNTSpasticity of childrenBotulinum toxin treatmentAdult spasticityTherapeutics subcommitteeBoNT treatmentPharmacologic treatmentFrequent symptomsMultiple sclerosisSpinal traumaClinical trialsToxin treatmentSpasticityAmerican AcademyPalsyBotulinum neurotoxinTreatmentChildrenWorld literatureEfficacyAdultsSclerosisPathophysiology
2015
Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
Schaefer SM, Gottschalk CH, Jabbari B. Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins. Toxins 2015, 7: 2615-2628. PMID: 26184313, PMCID: PMC4516932, DOI: 10.3390/toxins7072615.Peer-Reviewed Original ResearchConceptsChronic migraineBotulinum toxin injection therapyLarge healthcare costsBotulinum toxin therapyTreatment of migraineCommon neurological disorderToxin therapyInjection therapyPathophysiological mechanismsMigraine pathophysiologyHealthcare costsMigraineNeurological disordersAnimal dataBotulinum neurotoxinTherapyTreatmentInjection techniqueCurrent understandingMedicationsPathophysiology
2013
Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins 2013, 5: 1010-1031. PMID: 23698357, PMCID: PMC3709276, DOI: 10.3390/toxins5051010.Peer-Reviewed Original ResearchConceptsBotulinum toxinSide effectsAdministration of BoNTLevel B evidencePlacebo-controlled studyCurrent medical managementTroublesome side effectsLevel of evidenceOral agentsCerebral palsyClinical featuresExcessive droolingMedical managementTopical agentsB evidenceBlinded studyMedical treatmentAmerican AcademyClinical notesDrug efficacyNeurodegenerative disordersClinical pointB levelsSalivary glandsType BHyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
Lakraj AA, Moghimi N, Jabbari B. Hyperhidrosis: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins 2013, 5: 821-840. PMID: 23612753, PMCID: PMC3705293, DOI: 10.3390/toxins5040821.Peer-Reviewed Original ResearchConceptsClass II studiesII studyAxillary hyperhidrosisPalmar hyperhidrosisComparator studiesBotulinum toxinClass IEvidence level BLevel of evidenceClass III studiesOral agentsIII studyClinical featuresTopical agentsComparable efficacyLong lasting effectInjection sessionsBlinded studyAmerican AcademyDrug efficacyClass IIHyperhidrosisEfficacyWorld literatureToxin
2008
Botulinum neurotoxins in the treatment of refractory pain
Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nature Reviews Neurology 2008, 4: 676-685. PMID: 19043424, DOI: 10.1038/ncpneuro0948.Peer-Reviewed Original Research
2007
Treatment of chronic low back pain with botulinum neurotoxins
Jabbari B. Treatment of chronic low back pain with botulinum neurotoxins. Current Pain And Headache Reports 2007, 11: 352-358. PMID: 17894925, DOI: 10.1007/s11916-007-0217-1.Peer-Reviewed Original ResearchMeSH KeywordsBotulinum ToxinsClinical Trials as TopicHumansLow Back PainMuscle, SkeletalRandomized Controlled Trials as TopicConceptsLow back painChronic low back painBack painParaspinal musclesRefractory chronic low back painRefractory low back painFlu-like reactionsSignificant pain reliefOpen-label studyPlacebo-controlled studyBotulinum toxin ALumbar erector spinaeBotulinum treatmentPain reliefTechniques of treatmentLumbar levelsToxin AErector spinaePainSide effectsTrigger pointsInjection siteTotal dosePatientsEarly response
1994
Hypertrophic branchial myopathy treated with botulinum toxin type A.
Doyle M, Jabbari B. Hypertrophic branchial myopathy treated with botulinum toxin type A. Neurology 1994, 44: 1765-6. PMID: 7936316, DOI: 10.1212/wnl.44.9.1765.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply